Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19.
Terry Cheuk Fung YipGrace Chung-Yan LuiVincent Wai-Sun WongViola Chi-Ying ChowTracy Hang-Yee HoTimothy Chun-Man LiYee-Kit TseDavid Shu-Cheong HuiHenry Lik-Yuen ChanGrace Lai-Hung WongPublished in: Gut (2020)
ALT/AST elevation was common and independently associated with adverse clinical outcomes in COVID-19 patients. Use of lopinavir-ritonavir, with or without ribavirin, interferon beta and/or corticosteroids was independently associated with ALT/AST elevation.